# Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
Canonical URL: https://biopharmsignal.com/news/HYPR/hyperfine-reports-preliminary-unaudited-fourth-quarter-and-full-year-2025-financial-results
Ticker: HYPR
Company: Hyperfine
Source: Hyperfine
Published: 2026-01-12 13:15 EST
Original Source URL: https://investors.hyperfine.io
## Summary

Hyperfine Delivers Quarterly Record Revenue of Approximately $5.3 Million in Q4 2025, Representing Transformative Growth of 54% Compared to Prior Quarter; Exiting 2025 with Approximately $35 Million of Cash and Cash Equivalents. GUILFORD, Conn. --(BUSINESS WIRE)--Jan. 12, 2026-- Hyperfine, Inc.

## Article Body
Hyperfine Delivers Quarterly Record Revenue of Approximately $5.3 Million in Q4 2025, Representing Transformative Growth of 54% Compared to Prior Quarter; Exiting 2025 with Approximately $35 Million of Cash and Cash Equivalents. GUILFORD, Conn. --(BUSINESS WIRE)--Jan. 12, 2026-- Hyperfine, Inc.
## Recent Company News
- 2026-07-01 12:15 EST — [Hyperfine Announces European Launch of Next-Generation Swoop® System](https://biopharmsignal.com/news/HYPR/hyperfine-announces-european-launch-of-next-generation-swoop-system-eb9cfb69) — Source: Hyperfine
- 2026-06-22 12:15 EST — [Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care](https://biopharmsignal.com/news/HYPR/hyperfine-forms-global-neurosurgery-advisory-council-to-support-expansion-of-por-cc32f725) — Source: Hyperfine
- 2026-06-18 12:15 EST — [Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care](https://biopharmsignal.com/news/HYPR/hyperfine-swoop-system-scan-volume-in-the-united-states-hits-record-milestones-a-388aa4d6) — Source: Hyperfine
- 2026-05-26 12:15 EST — [Hyperfine to Join Russell 2000® and Russell 3000® Indexes](https://biopharmsignal.com/news/HYPR/hyperfine-to-join-russell-2000r-and-russell-3000r-indexes) — Source: Hyperfine
- 2026-05-22 12:15 EST — [Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments](https://biopharmsignal.com/news/HYPR/hyperfine-announces-presentation-of-results-from-the-prime-study-showing-portable-mri-substantially-reduces-time-to-imaging-in-emergency-departments) — Source: Hyperfine
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)